Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Bilow who wrote (712724)	5/1/2013 10:07:59 PM
From: i-node	Read Replies (3) \| Respond to of 1577953

I think this patent structure needs to be revised to provide incentives to drug companies to achieve desirable [from a public policy perspective] objectives. Ultimately, patents need to be tied to profitability, and some reasonable standards for measuring profitability of individual drugs need to be developed. I am amused at the availability of drugs for lengthening eyelashes, for example. I guess that's a big problem for someone, but hardly seems as though it should as much a priority as treatments for certain cancers, for example. But there is no way I think Congress should tackle a problem like this at this time. They're too big a mess and just need to go home.